• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由于装有109 mmol/L(3.2%)枸橼酸盐抗凝剂的标本管血量不足,导致凝血酶原时间和活化部分凝血活酶时间延长。

Prolonged prothrombin time and activated partial thromboplastin time due to underfilled specimen tubes with 109 mmol/L (3.2%) citrate anticoagulant.

作者信息

Reneke J, Etzell J, Leslie S, Ng V L, Gottfried E L

机构信息

Department of Laboratory Medicine, University of California San Francisco School of Medicine, San Francisco General Hospital, 94110, USA.

出版信息

Am J Clin Pathol. 1998 Jun;109(6):754-7. doi: 10.1093/ajcp/109.6.754.

DOI:10.1093/ajcp/109.6.754
PMID:9620035
Abstract

Underfilling of specimen tubes containing 129 mmol/L (3.8%) buffered citrate prolongs prothrombin time (PT) and activated partial thromboplastin time (APTT) values. We studied this phenomenon by using 109 mmol/L (3.2%) buffered citrate as the anticoagulant, anticipating some increase in tolerance to underfilling. Venous blood drawn from 12 healthy subjects and 30 patients receiving long-term oral warfarin therapy was mixed with 109 mmol/L buffered citrate solution in proportions equivalent to filling the collection tubes from 52% to 100% of capacity. Accurate PT values were obtained from normal specimens if the tubes were filled to 65% or more of capacity. Accurate PT results in the therapeutic range were obtained only with filling to 80% or more of capacity (using a "moderately sensitive" thromboplastin reagent, International Sensitivity Index [ISI] = 2.06) or 90% or more of capacity (using a "highly sensitive" thromboplastin reagent, ISI = 1.01). In contrast, APTT was much less tolerant to underfilling, with prolonged values observed in most specimens filled to less than 90% of capacity. No false low values were observed. Specimen tubes should be filled to at least 90% of capacity to avoid falsely elevated PT or APTT results, but values within the reference range may be acceptable even from underfilled tubes.

摘要

含有129 mmol/L(3.8%)缓冲枸橼酸盐的标本管填充不足会延长凝血酶原时间(PT)和活化部分凝血活酶时间(APTT)值。我们使用109 mmol/L(3.2%)缓冲枸橼酸盐作为抗凝剂研究了这一现象,预计对填充不足的耐受性会有所提高。从12名健康受试者和30名接受长期口服华法林治疗的患者采集的静脉血与109 mmol/L缓冲枸橼酸盐溶液按相当于将采集管填充至容量的52%至100%的比例混合。如果标本管填充至容量的65%或更多,则可从正常标本中获得准确的PT值。只有在填充至容量的80%或更多(使用“中度敏感”凝血活酶试剂,国际敏感指数[ISI]=2.06)或90%或更多(使用“高度敏感”凝血活酶试剂,ISI = 1.01)时,才能在治疗范围内获得准确的PT结果。相比之下,APTT对填充不足的耐受性要低得多,大多数填充至容量不到90%的标本中都观察到了值延长的情况。未观察到假低值。标本管应至少填充至容量的90%,以避免PT或APTT结果出现假性升高,但即使是填充不足的标本管,参考范围内的值也可能是可接受的。

相似文献

1
Prolonged prothrombin time and activated partial thromboplastin time due to underfilled specimen tubes with 109 mmol/L (3.2%) citrate anticoagulant.由于装有109 mmol/L(3.2%)枸橼酸盐抗凝剂的标本管血量不足,导致凝血酶原时间和活化部分凝血活酶时间延长。
Am J Clin Pathol. 1998 Jun;109(6):754-7. doi: 10.1093/ajcp/109.6.754.
2
Minimum specimen volume requirements for routine coagulation testing: dependence on citrate concentration.常规凝血检测的最低样本量要求:取决于枸橼酸盐浓度。
Am J Clin Pathol. 1998 May;109(5):595-9. doi: 10.1093/ajcp/109.5.595.
3
Use of EDTA samples for prothrombin time measurement in patients receiving oral anticoagulants.在接受口服抗凝剂治疗的患者中使用乙二胺四乙酸(EDTA)样本进行凝血酶原时间测定。
Haematologica. 2001 Aug;86(8):851-5.
4
The effects of inaccurate blood sample volume on prothrombin time (PT) and activated partial thromboplastin time (aPTT).血样体积不准确对凝血酶原时间(PT)和活化部分凝血活酶时间(aPTT)的影响。
Thromb Haemost. 1982 Apr 30;47(2):101-3.
5
Routine coagulation testing in Vacutainer® Citrate Plus tubes filled at minimum or optimal volume.在以最小或最佳体积填充的Vacutainer®柠檬酸盐加抗凝管中进行常规凝血检测。
Diagnosis (Berl). 2020 Jan 28;7(1):55-60. doi: 10.1515/dx-2019-0052.
6
Effect (or lack of it) of severe anemia on PT and APTT results.
Am J Clin Pathol. 1998 Jul;110(1):106-10. doi: 10.1093/ajcp/110.1.106.
7
A comparative study of conventional versus new, magnesium-poor Vacutainer® Sodium Citrate blood collection tubes for determination of prothrombin time and INR.用于测定凝血酶原时间和国际标准化比值的传统与新型低镁枸橼酸钠真空采血管的比较研究
Thromb Res. 2014 Jul;134(1):187-91. doi: 10.1016/j.thromres.2014.04.016. Epub 2014 Apr 26.
8
Effect of drawing a discard tube on PT and APTT results in healthy adults.抽取废弃管对健康成年人凝血酶原时间(PT)和活化部分凝血活酶时间(APTT)结果的影响。
Clin Lab Sci. 2003 Winter;16(1):16-9.
9
Influence of blood collection systems on the prothrombin time and international sensitivity index determined with human and rabbit thromboplastin reagents.采血系统对使用人源和兔源凝血活酶试剂测定的凝血酶原时间及国际敏感指数的影响。
Am J Clin Pathol. 2007 May;127(5):724-9. doi: 10.1309/NW194EAMD4WMEHJD.
10
Comparison between siliconized evacuated glass and plastic blood collection tubes for prothrombin time and activated partial thromboplastin time assay in normal patients, patients on oral anticoagulant therapy and patients with unfractioned heparin therapy.硅化真空采血管与塑料采血管在正常患者、口服抗凝治疗患者和未分馏肝素治疗患者的凝血酶原时间和活化部分凝血活酶时间测定中的比较。
Int J Lab Hematol. 2011 Apr;33(2):219-25. doi: 10.1111/j.1751-553X.2010.01271.x. Epub 2010 Oct 27.

引用本文的文献

1
Chromogenic and Clot-Based Bivalirudin Assays for Monitoring Anticoagulation.发色底物和基于凝血的比伐卢定检测在抗凝监测中的应用。
J Appl Lab Med. 2023 Nov 2;8(6):1074-1083. doi: 10.1093/jalm/jfad072.
2
Automation in the Thrombosis and Hemostasis Laboratory.自动化在血栓与止血实验室。
Methods Mol Biol. 2023;2663:51-62. doi: 10.1007/978-1-0716-3175-1_3.
3
Accuracy of Citrate Anticoagulant Amount, Volume, and Concentration in Evacuated Blood Collection Tubes Evaluated with UV Molecular Absorption Spectrometry on a Purified Water Model.
采用纯化水模型的紫外分子吸收光谱法评估真空采血管中枸橼酸盐抗凝剂的量、体积和浓度的准确性。
Molecules. 2023 Jan 4;28(2):486. doi: 10.3390/molecules28020486.
4
Effect of anticoagulant adjustment on prothrombin time test using two different PT reagents in patients with elevated hematocrit.血细胞比容升高患者中使用两种不同凝血酶原时间试剂时抗凝调整对凝血酶原时间检测的影响
Pract Lab Med. 2020 Oct 17;22:e00177. doi: 10.1016/j.plabm.2020.e00177. eCollection 2020 Nov.
5
Quantitative assessment of prevalence of pre-analytical variables and their effect on coagulation assay. Can intervention improve patient safety?分析前变量的患病率及其对凝血检测的影响的定量评估。干预能否提高患者安全性?
Med J Armed Forces India. 2017 Apr;73(2):152-158. doi: 10.1016/j.mjafi.2016.12.005. Epub 2017 Jan 5.
6
Influence of blood collection systems on coagulation tests.采血系统对凝血试验的影响。
Turk J Haematol. 2012 Dec;29(4):367-75. doi: 10.5505/tjh.2012.59254. Epub 2012 Dec 5.
7
Influence of blood specimen collection method on various preanalytical sample quality indicators.血液标本采集方法对各种分析前样本质量指标的影响。
Indian J Clin Biochem. 2008 Apr;23(2):144-9. doi: 10.1007/s12291-008-0032-4. Epub 2008 Jun 11.